Inc. ("TELUS Digital") (NYSE & TSX: TIXT) today announced that independent proxy advisory firm, Institutional Shareholder Services Inc. ("ISS"), has recommended that TELUS Digital shareholders vote ...
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that VEOZAHâ„¢ (fezolinetant), its first-in-class, targeted, non-hormonal treatment for moderate to severe ...